This review article provides a detailed examination of the pharmacologic properties of topical agents used in the treatment of superficial skin cancers such as actinic keratoses and basal cell carcinoma. It reviews the mechanisms of action, pharmacokinetics, formulations, clinical indications, adverse effect profiles, and contraindications of approved agents like 5-fluorouracil,
